Advisory Research Inc View Ray, Inc. Transaction History

Advisory Research Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$3.28 - $4.81 $314,079 - $460,586	-95,756 Reduced 21.33%	353,100 $1.22 Million
Q4 2022 Feb 13, 2023	BUY	$3.65 - $4.82 $19,242 - $25,411	5,272 Added 1.19%	448,856 $2.01 Million
Q3 2022 Nov 14, 2022	BUY	$2.66 - $3.97 $1.15 Million - $1.71 Million	431,390 Added 3537.72%	443,584 $1.61 Million
Q2 2022 Aug 17, 2022	SELL	$2.42 - $4.05 $1.17 Million - $1.96 Million	-483,454 Reduced 97.54%	12,194 $32,000
Q1 2022 May 16, 2022	SELL	$3.45 - $5.83 $464,666 - $785,219	-134,686 Reduced 21.37%	495,648 $1.94 Million
Q4 2021 Feb 11, 2022	BUY	$4.89 - $7.59 $123,736 - $192,057	25,304 Added 4.18%	630,334 $3.47 Million
Q3 2021 Nov 12, 2021	BUY	$5.18 - $7.41 $827,618 - $1.18 Million	159,772 Added 35.88%	605,030 $4.36 Million
Q2 2021 Aug 16, 2021	BUY	$3.94 - $6.75 $1.13 Million - $1.93 Million	286,203 Added 179.94%	445,258 $2.94 Million
Q1 2021 May 12, 2021	BUY	$4.03 - $7.25 $640,991 - $1.15 Million	159,055 New	159,055 $692,000
Q4 2020 Feb 12, 2021	SELL	$2.78 - $4.5 $139,897 - $226,453	-50,323 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$2.12 - $3.53 $106,684 - $177,640	50,323 New	50,323 $176,000
Q1 2020 May 12, 2020	SELL	$1.35 - $4.05 $278,640 - $835,920	-206,400 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$2.3 - $4.6 $474,719 - $949,439	206,400 New	206,400 $871,000

645K

50K

30K

Ticker VRAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 181,010,000
Market Cap $1.81M
Description
ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin tox...

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

Stay updated on Advisory Research Inc with notifications on news.